These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8880741)

  • 1. Separating dual effects of zinc at recombinant N-methyl-D-aspartate receptors.
    Williams K
    Neurosci Lett; 1996 Aug; 215(1):9-12. PubMed ID: 8880741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-affinity zinc inhibition of NMDA NR1-NR2A receptors.
    Paoletti P; Ascher P; Neyton J
    J Neurosci; 1997 Aug; 17(15):5711-25. PubMed ID: 9221770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential sensitivity of recombinant N-methyl-D-aspartate receptor subtypes to zinc inhibition.
    Chen N; Moshaver A; Raymond LA
    Mol Pharmacol; 1997 Jun; 51(6):1015-23. PubMed ID: 9187268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and mechanism of action of two histidine residues underlying high-affinity Zn2+ inhibition of the NMDA receptor.
    Choi YB; Lipton SA
    Neuron; 1999 May; 23(1):171-80. PubMed ID: 10402203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of NMDA receptor function by ketamine and magnesium. Part II: interactions with volatile anesthetics.
    Hollmann MW; Liu HT; Hoenemann CW; Liu WH; Durieux ME
    Anesth Analg; 2001 May; 92(5):1182-91. PubMed ID: 11323344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of acute and chronic ethanol exposure on heteromeric N-methyl-D-aspartate receptors expressed in HEK 293 cells.
    Blevins T; Mirshahi T; Chandler LJ; Woodward JJ
    J Neurochem; 1997 Dec; 69(6):2345-54. PubMed ID: 9375665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors.
    Williams K
    Mol Pharmacol; 1993 Oct; 44(4):851-9. PubMed ID: 7901753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission.
    Frizelle PA; Chen PE; Wyllie DJ
    Mol Pharmacol; 2006 Sep; 70(3):1022-32. PubMed ID: 16778008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethanol inhibition of recombinant NR1/2A receptors: effects of heavy metal chelators and a zinc-insensitive NR2A mutant.
    Woodward JJ; Smothers C
    Alcohol; 2003; 31(1-2):71-6. PubMed ID: 14615013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycine modulates ethanol inhibition of heteromeric N-methyl-D-aspartate receptors expressed in Xenopus oocytes.
    Buller AL; Larson HC; Morrisett RA; Monaghan DT
    Mol Pharmacol; 1995 Oct; 48(4):717-23. PubMed ID: 7476899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The N-terminal domains of both NR1 and NR2 subunits determine allosteric Zn2+ inhibition and glycine affinity of N-methyl-D-aspartate receptors.
    Madry C; Mesic I; Betz H; Laube B
    Mol Pharmacol; 2007 Dec; 72(6):1535-44. PubMed ID: 17878266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the NMDA response by pregnenolone sulphate reveals subtype selective modulation of NMDA receptors by sulphated steroids.
    Malayev A; Gibbs TT; Farb DH
    Br J Pharmacol; 2002 Feb; 135(4):901-9. PubMed ID: 11861317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of voltage-independent zinc inhibition of NMDA receptors by the NR1 subunit.
    Traynelis SF; Burgess MF; Zheng F; Lyuboslavsky P; Powers JL
    J Neurosci; 1998 Aug; 18(16):6163-75. PubMed ID: 9698310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subunit-specific potentiation of recombinant N-methyl-D-aspartate receptors by histamine.
    Williams K
    Mol Pharmacol; 1994 Sep; 46(3):531-41. PubMed ID: 7935335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits.
    Williams K; Zappia AM; Pritchett DB; Shen YM; Molinoff PB
    Mol Pharmacol; 1994 May; 45(5):803-9. PubMed ID: 8190097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of NMDA receptor function by ketamine and magnesium: Part I.
    Liu HT; Hollmann MW; Liu WH; Hoenemann CW; Durieux ME
    Anesth Analg; 2001 May; 92(5):1173-81. PubMed ID: 11323343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spermine potentiation of recombinant N-methyl-D-aspartate receptors is affected by subunit composition.
    Zhang L; Zheng X; Paupard MC; Wang AP; Santchi L; Friedman LK; Zukin RS; Bennett MV
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):10883-7. PubMed ID: 7971977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of spermine and ifenprodil to a purified, soluble regulatory domain of the N-methyl-D-aspartate receptor.
    Han X; Tomitori H; Mizuno S; Higashi K; Füll C; Fukiwake T; Terui Y; Leewanich P; Nishimura K; Toida T; Williams K; Kashiwagi K; Igarashi K
    J Neurochem; 2008 Dec; 107(6):1566-77. PubMed ID: 19014388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-affinity Zn block in recombinant N-methyl-D-aspartate receptors with cysteine substitutions at the Q/R/N site.
    Amar M; Perin-Dureau F; Neyton J
    Biophys J; 2001 Jul; 81(1):107-16. PubMed ID: 11423399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential modulation of NR1-NR2A and NR1-NR2B subtypes of NMDA receptor by PDZ domain-containing proteins.
    Iwamoto T; Yamada Y; Hori K; Watanabe Y; Sobue K; Inui M
    J Neurochem; 2004 Apr; 89(1):100-8. PubMed ID: 15030393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.